After numerous requests to find the answer to the question: Does the US Government really own patents on Ebola¹? It will be shown right now that yes, the Ebola virus was patented in October of 2009 and was published the following year. Its inventors were credited as Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, and Pierre E. Rollin.
But before we get into those names and information surrounding this unbelievable patent, let’s focus on the most interesting names to appear on it, which are listed beside the “Applicant” section in this picture:
As clear as day and taking responsibility is “The Government Of United States Of America” along with the CDC and the “Department of Health & Human Services.”
Does this mean the US Government actually invented Ebola?
No, not according to this patent at least it doesn’t. As it states, Ebola has existed for many decades and it’s unclear what it originated from, though it is known where:
“The family Filoviridae consists of two genera, Marburgvirus and Ebolavirus, which have likely evolved from a common ancestor’. The genus Ebolavirus includes four species: Zaire, Sudan, Reston and Cote d’Ivoire (Ivory Coast) ebolaviruses.”
As you may have noted, each strain of this disease is named for the African country it was first discovered in.
The patent goes on to state the belief is that Ebola Zaire — the strain of our current epidemic — was evolved in and carried originally by fruit bats:
“Identification of the natural reservoir of ebolaviruses remains somewhat elusive, although recent PCR and antibody data suggest that three species of arboreal fruit bats may be carriers of Zaire ebolavirus3.”
According to the summary, back in 2007, in Uganda, a deadly new form of Ebola swept across the land infecting 149 people, 37 of which died. It was from patients infected during this outbreak that a new species — labeled EboBun — was isolated and identified.
It’s important to note that while this patent is for EboBun, it also states the US Government is claiming “ownership” over any virus which shares as much as 70% of the attributes as Ebobun, which would include virtually all strains of Ebola.
It’s also very important to note that the US government is filing for a complete monopoly on anything to do with Ebola through this patent — which was granted — such as any vaccines, research, genetic isolations or manipulations, tests, and the companies and individuals hired to work on those things or anything related to them.
To clearly illustrate what this means, here’s the definition of what a patent is and does:
“A government authority or license conferring a right or title for a set period, especially the sole right to exclude others from making, using, or selling an invention.”
Who are the people listed as “inventors”?
These are the names of doctors assigned to work on genetically understanding and fighting Ebola. To me it’s more than curious they are referred to as “inventors”, but nonetheless the patent is clear when it states Ebola naturally evolved. It didn’t originate in some lab, as far as the patent tells us. Tellingly, they all work for the same company.
Jonathan S. Towner is a Virologist from the Center for Disease Control and Prevention (CDC) who has specialized in Filoviridae — the family of Ebola — for years now, publishing a number of papers on how the disease spreads and its hypothesised origins.
Stuart T. Nichol is Chief of the Molecular Biology Section, Special Pathogens Branch, at the Center for Disease Control (CDC) in Atlanta, Georgia. He was instrumental in the research done in the Crimean-Congo Hemorrhagic Fever, Sudan, 2008, case.
Dr. James “Andy” Comer is a Microbiologist from the CDC’s Special Pathogens Branch. He has travelled abroad and worked in West Africa on Ebola and Ebola related outbreaks since at least 2007.
Dr. Thomas G. Ksiazek is — or at least was in 2007 — the Chief of the CDC’s Special Pathogens Branch, and has been working on “the mechanisms of transmission from reservoir zoonotic hosts to humans as well as transmission of the viral hemorrhagic fever viruses from case to case, particularly in healthcare settings.” He personally dealt with the outbreak in Uganda in 2007 and has a 20-year history of tracking the reservoir hosts of filoviruses.
Dr. Pierre Rolland — MD from the Center for Disease Control — has specialized in Virology, Disease, and Plant & Animal service since before he began writing papers on those subjects in Paris in 1963. He was directly involved in the discovery and characterization of a slew of emerging diseases — Ebola hemorrhagic fever, Lassa fever, Marburg hemorrhagic fever, Sabia virus infection, hantavirus pulmonary syndrome, Rift Valley fever, Crimean-Congo hemorrhagic fever, Nipah encephalitis, and most recently severe acute respiratory syndrome. According to the CDC’s website, “His research interests concern emerging zoonotic and arthropod borne infectious diseases with emphasis on public health response and preparedness.”
Why does the CDC and US Gov’t have the patents in the first place?
First and foremost it’s important to note that in 2013 — after EboBun was patented — the United States Supreme Court ruled against a company called Myriad Genetics for trying to patent isolated genetic material — which is exactly what the CDC and US government patented relating to Ebola. Therefore by the rule of precedent it’s against the law for anybody to patent a naturally occurring disease in America. The Opinion of the Court stated:
“To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention… Had Myriad created an innovative method of manipulating genes while searching for the [specific] genes, it could possibly have sought a method patent. But the processes used by Myriad were well understood by geneticists at the time.”
Simply put: You can seek to patent the method to isolate a gene, but you can’t patent a living organism of any kind; and this includes Ebola. If you could patent living things I’m sure by now McDonalds would own every cow on earth, KFC would own all the chickens — and I guess eggs too — and the US Government would legally have the patent on humanity.
The fact of the matter is, those patents everybody is freaking out about are quite old, out of date, and technically void based on the results of the Association for Molecular Pathology vs. Myriad Genetics, INC. ruling of 2013.
This doesn’t, however, change the fact the United States government patented a monopoly on this infection before that trial. The reason why, well, we can only imagine. By patenting Ebola strains it is a clear indication that the US government has been seriously experimenting with the disease for at least 5 years now; some rumours say for decades. It also means they are the only authority who can produce a vaccine for Ebola. This is where profit comes into play, which always dirties the waters but clears the air for those looking to see things a little better.
Just think of it this way, if suddenly everyone needed a vaccination, and let’s say for the sake of simplicity that every dose costed $1 each, the company providing the vaccine would make $350,000,000 dollars in the US alone.
Commissioned by the United States Department of Defense, a company in Vancouver, Canada, called Tekmira — who just received $86.2 million from widely hated genetic modification giant and now partner Monsanto — is working on an Ebola vaccination that is currently going into its human testing stages. A quick look at their stock page on Investor.com shows their shares are growing at an almost exponential rate since early August when it was publicly released they were working on the vaccination:
Whether or not the Ebola patent is still legal by American standards, it doesn’t change the original intent of the authorities who sought to monopolise on it in the first place. The fact America patented a deadly disease 4 years before it became a worldwide outbreak is disturbingly suspicious to say the absolute least; and it is extra suspicious that the mainstream media has been silent about this monumental fact. This, in my opinion, isn’t something someone should learn by chance on the internet. This should be a worldwide headline and the American government should be answering some serious questions.
¹Specifically this is asked in relation to patent CA 2741523 A1.
By Olan Thomas of CUT2THETRUTH.com.